Cryoport, Inc. Form 8-K Summary
Business Context and Reporting Period
Cryoport, Inc. filed this Current Report on Form 8-K on October 14, 2010, to disclose the second closing of a private placement of securities that commenced in August 2010. The company is incorporated in Nevada and is headquartered in Lake Forest, California.
Key Financial Metrics
- Proceeds from Second Closing: Gross proceeds of $583,000; net proceeds of approximately $539,690 after cash offering expenses.
- Total Private Placement Proceeds: Approximately $3.6 million in net proceeds raised across the first and second closings.
- Securities Issued (Second Closing): 832,868 Units, each consisting of one share of Common Stock and one warrant.
- Warrant Terms: Exercise price of $0.77 per share; immediately exercisable with a five-year term.
- Placement Agent Compensation: Emergent Financial Group, Inc. received a 7% fee on gross proceeds plus $2,500 in expense reimbursement and a warrant to purchase 116,602 shares.
- Use of Proceeds: Working capital purposes.
Note: The filing does not provide specific data on revenue, profit, cash flow, margins, debt, or liquidity positions.
Material Changes
The primary material change is the increase in capitalization and cash reserves resulting from the second closing of the private placement. The company filed a registration statement on Form S-1 on October 19, 2010, to register the resale of shares issued to investors and placement agents in both closings.
Guidance, Outlook, and Risks
Management intends to utilize the raised capital for working capital purposes. The sale of securities was conducted under exemptions provided by Rule 505 and/or Rule 506 of Regulation D and/or Section 4(2) of the Securities Act of 1933. The filing notes that the summary of terms is qualified by reference to the full text of the Purchase Agreements and Registration Rights Agreement filed as exhibits.
Investor Verification Checklist
- Verify the total number of shares outstanding post-issuance of the 832,868 units and placement agent warrants.
- Confirm the dilution impact on existing shareholders from the total $3.6 million raise.
- Review the full text of the Purchase Agreements and Registration Rights Agreement filed as exhibits to the Form S-1 for specific covenants.
- Monitor the status of the Form S-1 registration statement filed on October 19, 2010, for the resale of securities.